Jon Stojan
With some of the biggest-selling probiotics on the market not backed up by significant data or scientific studies, unregulated dietary and recovery supplements can be dangerous—primarily because so little is generally known about how probiotics work.
Seeking to increase education and knowledge on the benefits of effective probiotics for overall health wellness, Dr. Yinka Davies is a gastroenterologist who focuses on gut immunology and has decades of experience in this field.
Dr. Davies brings her extensive research on microbiome health to her role as the founder and CEO of Lyvecap. This scientifically-backed probiotic system gives you back control over your gut health, energy, and endurance.
Dr. Davies Research Journey
During her fellowship at Stanford University, Dr. Davies met Dr. Claudio De Simone, a leader in intestinal microflora research. During this professional experience, Dr. Davies discovered the impact of using the right probiotic strains on one’s overall health, which stemmed from her clinical experience treating a child with an imbalanced gut microbiome.
“A lot of probiotics advertise as having 20 billion strains of bacteria, but the data shows it takes 200 billion strains to make a real difference to the way you feel,” stated Dr. Davies.
Through her experience in gastroenterology and research on microbiome health, Dr. Davies learned more about the role of probiotics in gut health, immune function, athletic performance, and particularly their ability to increase oxygenation (VO2max).
Recognizing that standard probiotics fail to make a positive difference and that Claudio De Simone’s formulation showed positive results, Dr. Davies co-founded Lyvecap with Dr. De Simone to create scientifically backed probiotics with proven efficacy.
Lyvecap
Launched in 2020, Lyvecap sets itself apart by combining the right strains in the right amounts. Backed by scientific rigor that differentiates it from generic probiotics, Lyvecap includes two patents and a unique eight-strain formula containing 200 billion colony-forming units, significantly more potent than standard probiotics. The company’s proprietary probiotic formulation has shown tangible health benefits, such as improved gut health and increased oxygenation (VO2 max).
During the COVID-19 pandemic, the company made a breakthrough discovery when the Lyvecap formulation was used in Italy. While helping alleviate gastrointestinal symptoms, the formula improved oxygen saturation levels in ICU patients, highlighting its potential to boost oxygenation. This discovery further showcases Lyvecap’s unique benefits to health and wellness.
While Lyvecap comes at a higher price, the probiotic system offers excellent value. Lyvecap Strong is listed at $150 a month, higher than most probiotics; however, if you break down this probiotic system per colony-forming units (CFUs), a unit that estimates the number of viable bacteria or fungi, Lyvecap is less expensive and offers more value. Backed by over 20 years of research and development, Lyvecap’s price directly reflects Lyvecap’s quality and proven results.
Challenges and the Future
One of Lyvecap’s biggest challenges is consumer education, which leads many individuals to seek out cheaper probiotics without understanding that most products available on the market are not backed by scientific research.
However, looking to the future, Lyvecap aims to educate the masses on microbiome health. Dr. Davies envisions Lyvecap becoming a household name by spreading awareness and education on the microbiome’s critical role in overall wellness.